(44) Other financial obligations
Other financial obligations comprised the following:
€ million |
|
Dec. 31, 2024 |
|
Dec. 31, 2023 |
---|---|---|---|---|
Acquisition of intangible assets |
|
745 |
|
1.431 |
Acquisition of property, plant, and equipment |
|
325 |
|
483 |
Other financial obligations |
|
1.071 |
|
1.914 |
Obligations to acquire intangible assets related to contingent considerations in connection with in-licensing agreements in particular. In these agreements, the Group has entered into an obligation to make milestone payments once specific targets have been reached. In the unlikely event that all of the milestones are achieved, the Group would be obligated to pay up to € 745 million (December 31, 2023: € 1,431 million) for the acquisition of intangible assets. The table above does not contain any other financial obligations from possible future sales-based royalties and milestone payments. The decline in other financial obligations to acquire intangible assets was primarily due to the discontinuation of the xevinapant program (see Note (7) “Collaboration and licensing agreements”).
The expected maturities of the obligations to acquire intangible assets were as follows:
€ million |
|
Dec. 31, 2024 |
|
Dec. 31, 2023 |
---|---|---|---|---|
Within 1 year |
|
38 |
|
278 |
In 1 – 5 years |
|
349 |
|
548 |
After more than 5 years |
|
359 |
|
604 |
Obligations to acquire intangible assets |
|
745 |
|
1.431 |
Other financial obligations were recognized at nominal value.